Alchemia Limited (ACL) - Research

$0.011

ACL General Information +

ASX Code ACL
Website http://www.alchemia.net.au
GICS Sub-Industry Biotechnology
Market Cap ($M) 3
Current Price $0.011
Day High $0.011
Day Low $0.010
Last Close $0.011
Price Movement - ( No change )
Prices as at 16:35, 24 May 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

ACL Company Overview

Business Description

Alchemia Limited (ACL) is a biotechnology company which develops new human therapeutics based on its proprietary drug discovery and expands drug targeting and synthesis technologies in Australia and USA.

ACL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -0.37 -0.10 0.00% 0.00 0.00 0.00% 0.0%
2017 A -0.54 -0.20 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.21 -1.00 0.00% 0.00 0.00 0.00% 0.0%

ACL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
Alchemia (ACL) $4M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL (CSL) $93,649M 0.3775 0.1394 0.1291 39.3751 34.5578 30.6057 1.49% 1.32% 1.52%
Clinuvel Pharmaceuticals (CUV) $1,527M 0.8671 0.0000 0.0000 116.8165 0.0000 0.0000 0.06% 0.00% 0.00%
Mesoblast (MSB) $758M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

ACL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.96 0.00
Market 0.92 17.10 1.53 1.61
Sector 1.03 25.30 3.35 2.10

ACL Directors

Name Position Start Date
Ms Melanie Jaye Leydin Chief Financial Officer, Company Secretary, Non-Executive Director 5 Mar 2019
Mr Lynden Polonsky Non-Executive Director 5 Mar 2019
Mr Cameron Petricevic Non-Executive Director, Non-Executive Chairman 6 Jun 2018

ACL Management

Name Position
Michael Sapountzis Joint Company Secretary

ACL Substantial Shareholders

Holding Name
39,426,777 (12.14%) Shomron Pty Ltd

ACL Calendar of Events

Date Event
26 February 2020 Report (Interim)
29 August 2019 Report (Annual)
29 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.